Performance Food Group Q2 Earnings Miss Expectations
Performance Food Group Co's stock fell 7.92% as it hit a 5-day low amid mixed market conditions.
The company reported a Q2 Non-GAAP EPS of $0.98, missing expectations by $0.11, which indicates pressure on profitability that could undermine investor confidence. Additionally, revenues of $16.4 billion, a 5.1% year-over-year increase, fell short of expectations by $110 million, reflecting intensified market competition and rising costs. The cautious outlook for Q3, with expected net sales between $16.0 billion and $16.3 billion, and a downgrade in full fiscal year 2026 Adjusted EBITDA expectations, further contribute to concerns about future growth.
These results highlight the challenges Performance Food Group faces in maintaining profitability amid a competitive landscape, which may lead to increased scrutiny from investors regarding its growth trajectory.
Trade with 70% Backtested Accuracy
Analyst Views on PFGC
About PFGC
About the author

- Deutsche Bank Upgrade: Deutsche Bank upgraded First Solar from hold to buy, citing its compelling fundamentals and strong balance sheet, making it an attractive option for investors in the U.S. panel production sector.
- TD Cowen Initiations: TD Cowen initiated coverage on US Foods, Chefs' Warehouse, and Performance Foods with buy ratings, projecting USFD to achieve 5% revenue growth and 20% EPS growth in the medium term, highlighting its diversified exposure to high-margin subsegments.
- Morgan Stanley on Kingsoft Cloud: Morgan Stanley initiated Kingsoft Cloud as overweight, noting its successful transition from a mid-tier cloud player to an AI cloud provider, with accelerating revenue and improving profitability supported by Xiaomi and Kingsoft Group's ecosystem.
- Goldman Sachs on Rentokil: Goldman Sachs upgraded Rentokil from neutral to buy, expecting steady improvement in organic growth in pest services, aiming for mid-single-digit organic growth by 2027 as the company's growth strategy takes effect.
- Price Fluctuation Analysis: JAVA's stock has a 52-week low of $63.67 and a high of $78.52, with the latest trade at $77.93, indicating that the stock is nearing its high point, reflecting market optimism about its future performance.
- Technical Analysis Tool: Comparing the latest stock price to the 200-day moving average provides investors with valuable insights for technical analysis, helping to assess long-term trends and potential buying opportunities.
- ETF Trading Mechanism: Exchange-traded funds (ETFs) trade similarly to stocks, where investors are buying and selling 'units' that can be created or destroyed based on investor demand, impacting the liquidity and market performance of the ETF.
- Liquidity Monitoring: Weekly monitoring of changes in shares outstanding for ETFs allows for the identification of those experiencing significant inflows or outflows, enabling timely adjustments to investment strategies based on market dynamics.
- Put Option Appeal: The current bid for the $90.00 put option is $2.25, and if an investor sells this option, they commit to buying the stock at $90.00, effectively lowering their cost basis to $87.75, which is approximately a 3% discount from the current price of $92.98, making it attractive for potential PFGC buyers.
- Yield Potential Analysis: Should the put option expire worthless, the premium would yield a 2.50% return on the cash commitment, translating to an annualized yield of 9.81%, referred to as YieldBoost, highlighting the strategy's potential appeal.
- Call Option Returns: The $95.00 call option has a current bid of $4.00; if an investor buys PFGC shares at $92.98 and sells this call option, they could achieve a total return of 6.47% if the stock is called away at expiration, showcasing the profit potential of this strategy.
- Risk-Reward Trade-off: The $95.00 call option has a 49% chance of expiring worthless, allowing investors to retain both their shares and the premium collected, which could enhance returns, with an annualized yield boost of 16.88%.
- Earnings Decline: Performance Food Group reported a net income of $41.7 million for Q3, translating to $0.27 per share, down from $58.3 million and $0.37 per share last year, indicating pressure from rising operating costs.
- Adjusted Earnings: Excluding certain items, the adjusted earnings per share stood at $0.80, reflecting the company's efforts in cost control, yet failing to offset the overall decline in profitability.
- Revenue Growth: The company achieved a 6.4% year-over-year revenue increase to $16.29 billion, primarily driven by an uptick in cases sold and higher selling prices per case due to inflation, suggesting robust market demand.
- Impact of Operating Costs: Despite revenue growth, net income decreased by $16.6 million, primarily due to increased operating expenses, highlighting the need for more effective cost management strategies to sustain profitability in the future.
- Earnings Announcement: Performance Food Group (PFGC) is set to release its Q3 earnings on May 6th before the market opens, with consensus EPS estimates at $0.78, reflecting a 1.3% year-over-year decline, while revenue is projected at $16.17 billion, indicating a 5.6% year-over-year increase.
- Historical Performance Review: Over the past two years, PFGC has only beaten EPS estimates 25% of the time and revenue estimates 50% of the time, indicating significant volatility in its performance and suggesting that investors should approach future results with caution.
- Estimate Revision Trends: In the last three months, EPS estimates have seen no upward revisions and 12 downward adjustments, while revenue estimates have experienced 2 upward revisions and 7 downward adjustments, reflecting a weakening market confidence in the company's future profitability.
- Market Response: Despite these challenges, food service companies are expected to benefit from agentic AI, and PFGC recently priced $1.06 billion in senior notes due in 2034, which may provide support for its future capital structure.
- Mortgage Stocks Rally: Shares of Fannie Mae and Freddie Mac surged over 30% on Monday after billionaire Bill Ackman labeled them as 'stupidly cheap' in a social media post, indicating strong market confidence in their future potential.
- Boston Scientific Downgrade: Boston Scientific's stock fell more than 9% after Raymond James downgraded it from strong buy to outperform, reflecting concerns over weakening trends in its key growth areas and leading investors to adopt a cautious stance on its future performance.
- Cybersecurity Gains: Palo Alto Networks saw its shares jump over 7% after CEO Nikesh Arora disclosed a $10 million stock purchase, demonstrating market confidence in the company's growth prospects amid rising demand for cybersecurity solutions.
- United Therapeutics Innovation: United Therapeutics' stock rose nearly 13%, reaching a 52-week high, following positive phase 3 clinical trial results for its main product Tyvaso, and its plan to seek priority FDA review to expand the drug's label, showcasing strategic advancements in lung disease treatment.











